Methyl-4-oxoretinoate
Methyl-4-oxoretinoate is a derivative of Retinoic acid (HY-14649) . Methyl-4-oxoretinoate inhibits TPA (HY-18739) -induced ornithine decarboxylase (ODC) activity, and carcinogen-induced papillomas in mouse skin[1].
Product Specifications
CAS Number
[38030-58-9]
UNSPSC
12352211
Hazard Statement
H302, H315, H360, H410
Target
Drug Derivative
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/methyl-4-oxoretinoate.html
Purity
98.75
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
COC(/C=C(C)/C=C/C=C(C)/C=C/C(C(C)(CC1)C)=C(C)C1=O)=O
Molecular Formula
C21H28O3
Molecular Weight
328.45
Precautions
H302, H315, H360, H410
References & Citations
[1]Shealy YF, et al., Cancer chemopreventive 3-substituted-4-oxoretinoic acids. J Med Chem. 1994 Sep 16;37 (19) :3051-6.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
